Product Information
RCGD 423 is a homodimeric, programmable molecule that can be used to induce the production of oncostatin M (OSM) in chondrocytes. The RCGD 423-induced OSM production leads to an increase in the activation of signalling pathways that lead to hypertrophy and follicle formation. RCGD 423 has the ability to modulate the atypical IL-6 mediated programme, which is responsible for the development of osteoarthritis. RCGD 423 is also being investigated as a potential treatment for other diseases, including cancer, inflammation and fibrosis.
Chemical properties
Technical inquiry about: 3D-IEA23791 RCGD 423
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
